percentage of people on glp 1 This is BIG news for weight loss in the U.S. 👀 GLP-1 medications are changing the conversation—because are finally getting help that works with their body. 📌 In 2025, about 12.4% GLP-1s and The Payer Predicament

Abstract Background: While dipeptidyl peptidase-4 inhibitors (DPP-4is) are linked to autoimmune skin diseases, comparative data on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) remain limited

Biomarkers such as VEGF levels, angiopoietin expression, and imaging data reflecting vascular remodeling can guide the use of antiangiogenic therapies in a context-specific manner (Ding and Zhang 2015)

Kimji's review of the literature and his patient experience round out the case for at-home microinfusion

This should be achieved while minimising the time in range for hypoglycaemia, aiming for less than 4% in a range of less than 3.9 mmol/L

PLoS Negl

A larva was considered dead if it exhibited no movement after gentle probing with a fine brush